Literature DB >> 26459475

Effects of RHAMM/HMMR-Selective Peptides on Survival of Breast Cancer Cells.

N P Akent'eva1, S S Shushanov2, A I Kotel'nikov3.   

Abstract

RHAMM-selective peptides in a concentration of 10 μg/ml (2×10(-7) M) inhibited the growth of MDA-MB-231 breast cancer cells over 48 h. Treatment of cancer cells with RHAMM-selective peptides induced apoptosis and necrosis and increased caspase-3 activity (by 30%).

Entities:  

Keywords:  RHAMM-selective peptides; RHAMM/HMMR (hyaluronan-mediated motility receptor); apoptosis; breast cancer; necrosis

Mesh:

Substances:

Year:  2015        PMID: 26459475     DOI: 10.1007/s10517-015-3041-3

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells.

Authors:  Wei Liu; Jun Ma; Yong Cheng; Hongbo Zhang; Wengguang Luo; Hongyan Zhang
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-11-24

2.  Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis.

Authors:  JinHui Liu; ShuLin Zhou; SiYue Li; Yi Jiang; YiCong Wan; XiaoLing Ma; WenJun Cheng
Journal:  Cancer Cell Int       Date:  2019-05-20       Impact factor: 5.722

Review 3.  The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities.

Authors:  Josephine A Hinneh; Joanna L Gillis; Nicole L Moore; Lisa M Butler; Margaret M Centenera
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.